Ophthotech Corporation today announced that data from a large, prospective, randomized, controlled Phase 2b clinical trial of Ophthotech’s Fovista anti-PDGF therapy (1.5 mg) in patients with neovascular age-related macular degeneration (wet AMD) will b…
Author: The Medical News
Leaders come together to discuss latest advances in neurosciences
Stony Brook Medicine’s Neurosciences Institute brings together leaders in the field of neurosciences to present the latest advances in research and clinical care for neurodegenerative disorders, neuropsychiatric disorders, and neuro-ophthalmology.
Study reveals key chemical process that corrects potential visual errors in low-light conditions
On the road at night or on a tennis court at dusk, the eye can be deceived. Vision is not as sharp as in the light of day, and detecting a bicyclist on the road or a careening tennis ball can be tough.
Clinical and demographic factors impact visual acuity in retinal vasculitis
Just over one-third of individuals with retinal vasculitis will experience vision loss despite undergoing therapy for the condition, while approximately the same proportion will experience some improvement, show study results.
Quick, cheap eye scan can predict brain damage in people with multiple sclerosis
An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, according to results of two…
Vision care providers worry about effect of reporting driving concerns
Two-thirds of vision care providers routinely enquire about their older patients’ driving, while almost half believe that reporting patients negatively to government agencies affects the physician–patient relationship, show US study results.
Abnormal visual processing and circuitry in the brain impacts fixational saccades
Little is known about oculomotor function in amblyopia, or “lazy eye,” despite the special role of eye movements in vision. A group of scientists has discovered that abnormal visual processing and circuitry in the brain have an impact on fixational sac…
Antibiotic injections are associated with lower risk of infection in cataract surgery
Intracameral antibiotic injections were associated with a 22-fold reduction in the risk of postoperative infection following cataract surgery when compared with the standard post-operative treatment of antibiotic eyedrops, according to a Kaiser Permane…
Experts discuss recent U.S. meningitis outbreak at ANESTHESIOLOGY 2012 meeting
Four experts in anesthesiology, infectious disease and pain medicine discussed the recent U.S. meningitis outbreak in the Late-Breaking Education Panel, “The Fungal Meningitis Crisis,” on Sunday, Oct. 14.
Einstein College receives $3M grant to establish Glenn Center for the Biology of Human Aging Research
Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to tran…
Cigarette smoking may increase risk of age-related cataract
Cigarette smoking is a well-known risk factor for a wide-range of diseases. Now, scientists have evidence that smoking may also increase the risk of age-related cataract, the leading cause of blindness and vision loss in the world.
NYSCF conference to discuss latest advances in stem cell research
Leaders in translational stem cell research from across the country and around the world will present findings on how advances in stem cell science lead to better treatments and cures to disease and injury at The New York Stem Cell Foundation’s Seventh…
Ranibizumab improves driving prospects for AMD patients
Treatment with ranibizumab can preserve and even improve the perceived driving ability of patients with age-related macular degeneration, show the results of two randomized trials.
NACA could prevent or cure cataracts, macular degeneration and other eye conditions
Researchers at Missouri University of Science and Technology are working with an antioxidant that could prevent or cure cataracts, macular degeneration and other degenerative eye disorders.
Heavy caffeinated coffee consumption may increase risk of exfoliation glaucoma
A new study suggests caffeinated coffee drinkers should limit their intake to reduce their chances of developing vision loss or blindness. According to a scientific paper in Investigative Ophthalmology & Visual Science, heavy caffeinated coffee consump…
Ranibizumab injections keep those with AMD driving longer
The advanced neovascular, or “wet,” form of age-related macular degeneration (AMD), left untreated, is the most common cause of vision loss among the elderly and a leading reason for their loss of driving privileges. But results of a new study, pub…
FDA panel recommends U.S. approval for Second Sight’s Argus II bionic eye
On Friday September 28th, a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel unanimously voted 19-0 that the probable benefit of the Argus II Retinal Prosthesis System outweighs the risks to health, an important step toward the…
Experimental stem cell treatment improves vision in blind mice
An experimental treatment for blindness, developed from a patient’s skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
Statins linked to reduced glaucoma risk
Cholesterol-lowering medications in the statin class could significantly reduce the risk for developing open-angle glaucoma, show data for more than 500,000 older-age US individuals with hyperlipidemia.
Statins may protect against glaucoma
People who take statins to reduce their risk of cardiovascular disease are less likely to be diagnosed with the most common form of glaucoma, according to a nationwide study of more than 300,000 patients.